Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Curriculum Vitae KAY W CHANG, MD Office address: 801 Welch Road Stanford, CA 94305 Office: (650) 736-1314 PRESENT POSITION Associate Professor, Department of Otolaryngology, Stanford University March 1, 2008 – present Assistant Professor, Department of Otolaryngology, Stanford University August 16, 2000 – February 29, 2008 EDUCATION Brown University, Providence, RI B.A. (Cognitive and Linguistic Sciences) magna cum laude, 1985-89 Brown University School of Medicine, Providence, RI M.D. Sigma Xi, 1988-92 POSTGRADUATE TRAINING Surgery Intern, University of Washington, Seattle, WA, 1992-93 Otolaryngology Postdoctoral Research Fellow, University of Washington, Seattle, WA, 1993-94 Otolaryngology Resident, University of Washington, Seattle, WA, 1994-98 Pediatric Otolaryngology Fellow, Children’s Hospital of Pittsburgh, PA, 1998-2000 LICENSURE AND CERTIFICATION American Board of Otolaryngology (Certificate # 15149), 1999 State of California (License # G85741), 2000 PROFESSIONAL SOCIETIES American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS), 1994 Pediatric Otolaryngology Committee, appointed 10/1/09 – 9/30/2011 CPT/RVU Committee, ASPO SSAC representative, 3/2011 – 9/30/2015 Hearing Committee, appointed 10/1/13 – 9/30/2017 AAO-HNS Foundation Honor Award, 2013 Association for Research in Otolaryngology (ARO), 1995 Children’s Oncology Group (COG), 2003 Society for Ear, Nose and Throat Advances in Children (SENTAC), 2004 American Society of Pediatric Otolaryngology (ASPO), 2005 Pediatric Otology Study Group, 2007Nominating Committee, 2009-2010, 2014 Membership Committee, 2010-2012 Finance Committee, 2010-12 Chair of Finance Committee, 2012-14 Audit Committee, 2014-16 Curriculum Vitae Kay W. Chang, MD International Society of Pediatric Oncology (SIOP) Co-Chair Ototoxicity Consensus Conference, October 2010 Triologic Society, 2011 Program Advisory Committee for Combined Sections Meeting, Hotel del Coronado, San Diego, CA, January 22-24, 2015 American Otological Society (AOS), 2014 International Society for Auricular Reconstruction (ISAR), 2014 Presented keynote at 1st Congress of the International Society of Auricular Reconstruction, Paris, France, September 27, 2014 HONORS AND AWARDS USA Presidential Scholar (Connecticut), 1985 Phi Beta Kappa, 1988 Magna Cum Laude, Brown University, 1989 Milton Hamolsky Prize, to outstanding PLME graduate, 1989 Leonard H. Campbell Scholarship, Brown University School of Medicine, 1991 Henry Randall Prize, to outstanding MD graduate planning a surgical career, 1992 Sigma Xi, 1992 Sigma Xi Award, for outstanding medical research, 1992 1995 Association for Research in Otolaryngology Resident Travel Award Resident Teacher of the Year Award, Department of Otolaryngology, Stanford University, 2003 “Excellence in Teaching” award for medical student teaching, Stanford University, 2004 Best Doctors in America, 2005-2016 America’s Registry of Outstanding Professionals, 2006 Resident Teacher of the Year Award, Department of Otolaryngology, Stanford University, 2010 Patients’ Choice Award, 2011-2014 Top Ten Doctors (Vitals), 2012-2013 Castle Connolly’s Top Doctors, 2012-2015 AAO-HNS Foundation Honor Award, 2013 GRANTS Efferent regulation of the cochlear amplifier. Deafness Research Foundation (1996) $15,000. SERVICE TO STANFORD UNIVERSITY / LUCILE PACKARD CHILDREN’S HOSPITAL LPCH Care Improvement Committee, 2001-2011 Director of Medical Student Programs, Dept. of Otolaryngology, 2002-2011 LPCH Policy Committee, 2004-2005 2 Curriculum Vitae Kay W. Chang, MD MD Cerner Advisory Committee, 2005 Stanford Medical School Faculty Senate, 2005-2008 Ped/OB FPO Finance Committee, 2005-present Committee for Courses and Curriculum (CCC) Physical Exam Task Force, 2006-2010 Stanford Faculty Fellows Program, 2009 Advanced Stanford Leadership Development Program, 2012 LPCH Perioperative Services RPI #9: ENT Patient Flow, Physician lead, 2012 LPCH Enterprise-Wide Scheduling Initiative, Physician Leadership, Executive Steering Committee, 2012 LPCH Information Services Physician Advisory Group (ISPAG), 2012-present SERVICE TO PROFESSIONAL PUBLICATIONS Otology and Neurotology (Editorial Board, 2012-) Manuscript Reviewer, 2001Otolaryngology-Head and Neck Surgery (Editorial Board, 2009-2014) Manuscript Reviewer, 2004Received “Top Ten Reviewer” award for 2009 Cleft Palate Craniofacial Journal Manuscript Reviewer, 2003Pediatric Blood & Cancer Manuscript Reviewer, 2003Journal of Clinical Oncology Manuscript Reviewer, 2004American Journal of Rhinology Manuscript Reviewer, 2005Experimental Biology and Medicine Manuscript Reviewer, 2006Journal of Pediatrics Manuscript Reviewer, 2008Archives of Otolaryngology—Head & Neck Surgery Manuscript Reviewer, 2008International Journal of Pediatric Otorhinolaryngology Manuscript Reviewer, 2009Postgraduate Medical Journal Manuscript Reviewer, 2009Archives of Disease in Childhood Manuscript Reviewer, 2009Pediatrics Manuscript Reviewer, 2010- 3 Curriculum Vitae Kay W. Chang, MD 4 Journal of Pediatric Hematology and Oncology Manuscript Reviewer, 2010Journal of Medical Screening Manuscript Reviewer, 2010Pediatric Pulmonology Manuscript Reviewer, 2010Laryngoscope Manuscript Reviewer, 2011Annals of Otology, Rhinology, and Laryngology Manuscript Reviewer, 2011Chemotherapy Manuscript Reviewer, 2012Medicinal Research Reviews Manuscript Reviewer, 2014PEER REVIEWED PUBLICATIONS PUBLISHED 1. Chang KW, Vohr BR, Norton SJ, Lekas MD. External and middle ear status related to evoked otoacoustic emission in neonates. Arch Otolaryngol Head Neck Surg, 1993;119:276-282. [impact factor 2.33] 2. McRae RG, Weissburg AJ, Chang KW. Iatrogenic hyponatremia: a cause of death following pediatric tonsillectomy. Int J Pediatr Otorhinolaryngol, 1994;30:227-232. [impact factor 1.4] 3. Chang KW, Norton SJ. The effects of continuous versus interrupted noise exposures on distortion product otoacoustic emissions in guinea pigs. Hearing Research, 1996;96:1-12. [impact factor 3.14] 4. Chang KW, Inglis AF. Evaluation and management of hoarseness in children. Current Opinion Oto Head Neck Surg, 1996;4:396-400. [impact factor 2.0] 5. Chang KW, Norton SJ. Efferently mediated changes in the quadratic distortion product (f2 f1). J Acoust Soc Am , 1997;102:1719-1733. [impact factor 1.74] 6. Steinbach WJ, Sectich TC, Benjamin DK, Chang KW, Messner AH (2002) Pediatric residents’ clinical diagnostic accuracy of otitis media. Pediatrics, 2002;109(6):993-8. [impact factor 6.2] 7. Choe W, Chinosornvatana N, Chang KW. Prevention of Cisplatin ototoxicity using transtympanic N-acetylcysteine and lactate. Otology & Neurotology, 2004;25(6):910-5. [impact factor 2.0] 8. Katzenstein HM, Chang K, Krailo M, Bowman L, Greffe B, Castleberry R, Malogolowkin M. A randomized study of platinum-based chemotherapy with or without amifostine for the treatment of children with hepatoblastoma: A report of the Intergroup Hepatoblastoma Study P9645. Proc Am Soc Clin Oncol. 2004;22:8518. 9. Chang KW. Randomized controlled trial of Coblation versus electrocautery tonsillectomy. Otolaryngol Head Neck Surg, 2005;132(2):273-80. [impact factor 2.0] 10. Agarwal S, Hong DK, Soslow J, Chang KW. Not your routine foreign body: Endobronchial tuberculosis in an infant. Pediatrics, 2005;116(1):246-8. [impact factor 6.2] Curriculum Vitae Kay W. Chang, MD 5 11. Marina N, Chang KW, Malogolowkin M, London WB, Frazier AL, Womer RB, Rescorla F, Billmire DF, Davis MM, Perlman EJ, Giller R, Lauer SJ, Olson TA. Amifostine does not protect against the ototoxicity of high-dose cisplatin, etoposide and pleomycin (HD-PEB) in pediatric germ cell tumors (PGCT): A Children’s Oncology Group (COG) study. Cancer, 2005;104(4):841-7. [impact factor 5.4] 12. Rosen FS, Bingham D, Chang KW. Posttransplantation lymphoproliferative disorder of the paranasal sinuses in a child. Int J Pediatr Otorhinolaryngol Extra, 2006;1(1):22-26. [impact factor 1.4] 13. Chen JL, Messner AM, Chang KW. Familial laryngomalacia in two siblings with syndromic features. Int J Pediatr Otorhinolaryngol, 2006;70(9):1651-5. [impact factor 1.4] 14. Schrijver I, Chang KW. Two patients with the V37I/235delC genotype: Are radiographic cochlear anomalies part of the phenotype? Int J Pediatr Otorhinolaryngol, 2006;70(12):2109-13. [impact factor 1.4] 15. Truong MT, Winzelberg J, Chang KW. Recovery from cisplatin-induced ototoxicity. Int J Pediatr Otorhinolaryngol, 2007;71(10):1631-1638. [impact factor 1.4] 16. Chang KW, Lee BG, Gutierrez KM. Third branchial cleft fistula infected with Actinomyces. Int J Pediatr Otorhinolaryngol Extra, 2008;3(1):20-23. [impact factor 1.4] 17. Chen JL, Gittleman A, Barnes PD, Chang KW. Utility of temporal bone computed tomographic measurements in the evaluation of inner ear malformations. Arch Otolaryngol Head Neck Surg, 2008;134(1):50-56. [impact factor 2.33] 18. Chang KW. Intracapsular versus subcapsular Coblation tonsillectomy. Otolaryngol Head Neck Surg, 2008;138(2):153-7. [impact factor 2.0] 19. Mogensen MA, Lin AC, Chang KW, Berry GJ, Barnes PD, Fischbein NJ. Salivary Gland Anlage Tumor in a Neonate Presenting with Respiratory Distress: Radiographic and Pathologic Correlation. Am J Neuroradiol. 2009;30(5):1022-3. [impact factor 3.9] 20. Chang KW, O-Lee TJ, Price M. Evaluation of unilateral referrals on neonatal hearing screening. J Med Screening, 2009;16(1):17-21. [impact factor 3.1] 21. Curtin G, Messner AH, Chang KW. Otorrhea in infants with tympanostomy tubes before and after surgical repair of a cleft palate. Arch Otolaryngol Head Neck Surg, 2009;135(8):748-51. [impact factor 2.33] 22. Katzenstein HM, Chang KW, Krailo M, Chen Z, Bowman LC, Finegold MJ, Rowland J, Greffe B, Reynolds M, Newman K, Womer R, Castleberry RP, Pappo A, London W, Malogolowkin M. Amifostine does not prevent platinum-induced ototoxicity in children with hepatoblastoma. A report of the Intergroup Hepatoblastoma Study P9645. Cancer, 2009;115(24):5828-35. [impact factor 5.4] 23. Truong MT, Chang KW, Berk DR, Heerema-McKenney A, Bruckner AL. Propranolol for the treatment of a life-threatening subglottic and mediastinal infantile hemangioma. J Pediatrics, 2010;156(2):335-8. [impact factor 4.2] 24. Chan DK, Schrijver I, Chang KW. Connexin-26-associated deafness: Phenotypic variability and progression of hearing loss. Genet Med. 2010;12(3):174-81. [impact factor 7.33] 25. Chang KW, Chinosornvatana N. Practical grading system for evaluating cisplatin ototoxicity in children. J Clin Onc. 2010;28(10):1788-95. [impact factor 18.4] 26. Truong MT, Perkins JA, Messner AH, Chang KW. Propranolol for the treatment of airway hemangiomas: a case series and treatment algorithm. Int J Pediatr Otorhinolaryngol. 2010;74(9):1043-8. [impact factor 1.4] Curriculum Vitae Kay W. Chang, MD 6 27. Chan DK, Schrijver I, Chang KW. Diagnostic yield in the workup of congenital sensorineural hearing loss is dependent on patient ethnicity. Otology & Neurotology, 2011;32(1):81-7. [impact factor 2.0] 28. Kohlberg GD, Truong MT, Chang KW. Wegener’s granulomatosis in an adolescent presenting with pachymeningitis, mastoid effusion and Horner’s syndrome. Int J Pediatr Otorhinolaryngol Extra, 2011;6(2):80-84. [impact factor 1.4] 29. Chang KW. Clinically accurate assessment and grading of ototoxicity. (Triologic Thesis) Laryngoscope, 2011;121(12):2649-57. [impact factor 2.33] 30. Mori M, Chang KW. CT analysis demonstrates that cochlear height does not change with age. Am J Neuroradiol, 2012;33(1):119-23. [impact factor 3.9] 31. Gurgel RK, Popelka GR, Oghalai JS, Blevins NH, Chang KW, Jackler RK. Is it valid to calculate the 3-kilohertz threshold by averaging 2 and 4 kilohertz? Otolaryngol Head Neck Surg, 2012;147(1):102-4. [impact factor 2.0] 32. Brock PR, Knight KR, Campbell KC, Steyger PS, Blakley BW, Rassekh SR, Chang KW, Fligor BJ, Raijput K, Sullivan M, Neuwelt EA. Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale. J Clin Onc, 2012;30(19):2408-17. [impact factor 18.4] 33. Chisholm KM, Chang KW, Truong MT, Kwok S, West RB, Heerema-McKenney AE. BAdrenergic receptor expression in vascular tumors. Modern Pathology, 2012 Nov;25(11):144651. [impact factor 6.2] 34. Huoh KC, Chang KW. Lip Abscess Associated with Isotretinoin Treatment of Acne Vulgaris. JAMA Dermatology, 2013 Aug 1;149(8):960-1. [impact factor 4.8] 35. Nadaraja GS, Gurgel RK, Kim J, Chang KW. Hearing outcomes of atresia surgery versus osseointegrated bone conduction device in patients with congenital aural atresia: a systematic review. Otology & Neurotology, 2013 Oct;34(8):1394-9. [impact factor 2.0] 36. Chan DK, Chang KW. GJB2-associated hearing loss: Systematic review of worldwide prevalence, genotype, and auditory phenotype. Laryngoscope, 2014 Feb;124(2):E34-53. [impact factor 2.33] 37. Hoff SR, Chang KW. The proximal bronchoplasty retrieval technique for removal of embedded distal airway foreign bodies. Int J Pediatr Otorhinolaryngol, 2014 Jan;78(1):148-51. [impact factor 1.4] 38. Bass JK, Huang J, Onar-Thomas A, Chang KW, Bhagat SP, Chintagumpala M, Bartels U, Gururangan S, Hassall T, Heath J, McCowage G, Cohn R, Fisher M, Robinson G, Broniscer A, Gajjar A, Gurney JG. Concordance between the Chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma. Pediatric Blood & Cancer, 2014 Apr;61(4):601-5. [impact factor 2.4] 39. Czechowicz JA, Chang KW. Analysis of growth curves in children after adenotonsillectomy. JAMA Otolaryngol, 2014 Jun;140(6):491-6. [impact factor 1.8] 40. Colevas AD, Lira RR, Colevas EA, Lavori PW, Chang KW. Hearing evaluation of head and neck cancer patients (HNCP): Comparison of CTCAE, Brock and Chang adverse event (AE) criteria in patients receiving cisplatin. Head Neck, 2015;37(8):1102-7. [impact factor 2.73] 41. Czechowicz JA, Chang KW. Catch-up growth in infants with laryngomalacia after supraglottoplasty. Int J Pediatr Otorhinolaryngol, 2015 Aug;79(8):1333-6. [impact factor 1.4] Curriculum Vitae Kay W. Chang, MD 7 42. Chang KW. Genetics of hearing loss – Nonsyndromic. Otolaryngol Clin North Am, 2015 Dec;48(6):1063-72. [impact factor 1.76] 43. Amoils M, Chang KW, Saynina O, Wise PH, Honkanen A. Perioperative complications in pediatric tonsillectomy and adenoidectomy in ambulatory vs inpatient settings: Lessons learned from administrative data query. JAMA Otolaryngology, 2016 Feb 25 [Epub ahead of print] [impact factor 2.1] 44. Bass JK, Hua C, Huang J, Onar-Thomas J, Ness KK, Jones S, White S, Bhagat SP, Chang KW, Merchant TE. Hearing loss in patients who received cranial radiation therapy for childhood cancer. J Clin Onc, 2016 Jan 25. [Epub ahead of print] [impact factor 18.4] 45. Bass JK, Knight KR, Yock TI, Chang KW, Cipkala D, Grewal, SS. Evaluation and management of hearing loss in survivors of childhood and adolescent cancers. Pediatric Blood & Cancer. 2016 Feb 29 [Epub ahead of print] [impact factor 2.4] 46. Shan J, Guo Y, Chang KW, Zhang T. A modified technique for firm elevation of the reconstructed auricle. Eur Arch Otorhinolaryngol, 2016 Jan 18. [Epub ahead of print] [impact factor 1.6] BOOK CHAPTERS 1. Chang KW, Inglis AF. Sinusitis. Conn’s Current Therapy, 1997;Section 3:235-237. 2. Chang KW, Bluestone CD. Middle ear trauma. Gellis and Kagan's Current Pediatric Therapy 17th edition, 2002. p. 941. 3. Conner GH, Chang KW. Idiopathic conditions of the mouth and pharynx. Chapter 64 (pp.1242-1250). Pediatric Otolaryngology (ed: Bluestone, Stool, et al), 4th edition, 2003. 4. Messner AH, Chang KW. Pediatric Otolaryngology. Chapter 12.3 (pp.953-970). Anesthesiologist’s Manual of Surgical Procedures (ed: Jaffe & Samuels), 3 rd edition, 2004. 5. Chang KW. Complications of otitis media. Audio-Digest Otolaryngology Volume 40 Issue 1, January 7, 2007. 6. Chang KW. Atypical mycobacterial infections. Audio-Digest Otolaryngology Volume 40 Issue 1, January 7, 2007. 7. Chang KW. Laryngeal stenosis. Audio-Digest Otolaryngology Volume 41 Issue 18, September 21, 2008. 8. Chang KW. The latest techniques in tonsillectomy. Audio-Digest Otolaryngology Volume 41 Issue 24, December 21, 2008. 9. Messner AH, Chang KW, Chen M, Lammers CR, Hammer GB. Pediatric Otolaryngology. Chapter 12.3 (pp.1179-1199). Anesthesiologist’s Manual of Surgical Procedures (ed: Jaffe RA & Samuels SI), 4th edition, 2009. 10. Chang KW. How to avoid missing a cholesteatoma. Audio-Digest Otolaryngology Volume 44 Issue 13, July 7, 2011. 11. Hoff SR, Chang KW. Pharyngitis. Chapter 52 (pp.757-769). Bailey’s Head & Neck Surgery – Otolaryngology (ed: Johnson & Rosen), 5th edition, 2014. 12. Chang KW. Ototoxicity. Chapter 158 (pp.2542-2555). Bailey’s Head & Neck Surgery – Otolaryngology (ed: Johnson & Rosen), 5th edition, 2014. 13. Chang KW. Coblation techniques. Audio-Digest Otolaryngology Volume 47 Issue 23, December 7, 2014. Curriculum Vitae Kay W. Chang, MD 8 14. Chang KW. Management of atresia and microtia. Audio-Digest Otolaryngology Volume 48 Issue 2, January 21, 2015. ABSTRACTS 1. Chang KW, Norton SJ. Efferently mediated changes in the acoustic QDT. Eighteenth Midwinter Meeting of the Association for Research in Otolaryngology, Feb. 5-9, 1995, St. Petersburg Beach, Florida, p. 173. 2. Chang KW, Norton SJ. The efferents play a role in the adaptation of the cochlear amplifier to acoustic stimulation. Nineteenth Midwinter Meeting of the Association for Research in Otolaryngology, Feb. 4-8, 1996, St. Petersburg Beach, Florida, p. 23. NATIONAL AND INTERNATIONAL PRESENTATIONS 1. Chang KW, Vohr BR, Norton SJ, Lekas MD. “External canal and middle ear status in full term neonates related to evoked otoacoustic emission.” Presented at American Pediatric Society/Society for Pediatric Research joint annual meeting, Baltimore, May 4-7, 1992. 2. McRae R, Weissberg A, Chang KW. “Iatrogenic hyponatremia: A cause of death following pediatric tonsillectomy.” Presented at 1992 Eastern Section Meeting of the Triological Society, The Grand Hyatt Hotel, New York, January 30, 1993. 3. Chang KW, Pinczower EF. “Stapes gusher.” Presented at Northwest Academy of Otolaryngology Head and Neck Surgery Spring Meeting, Chateau Whistler Resort, Whistler, British Columbia, April 12, 1997. 4. Chang KW, Darden D, Dohar J. “Pediatric tracheotomy - Is postoperative chest x-ray necessary?” Presented at 14th Annual American Society of Pediatric Otolaryngology Meeting, Marriott’s Desert Springs, Palm Desert, CA, April 28-30, 1999. 5. Chang KW, Casselbrant ML, Furman JM, Redfern MS, Mandel EM, Fall PA. “Otitis media and balance.” Presented at 7th International Symposium on Recent Advances in Otitis Media, Marriott Harbor Beach Resort, Fort Lauderdale, FL, June 1-5, 1999. 6. Chang KW. “Lye Ingestion.” Presented at American Society of Pediatric Otolaryngology, Eastern Section Meeting, Hilton Hotel, Pittsburgh, PA, January 28, 2000. 7. Chang KW. “Cisplatin ototoxicity.” Invited guest for Children’s Oncology Group 2003 Spring Group Meeting, Atlanta, Georgia. Rare Tumor Committee, Germ Cell Tumor Subcommittee, March 27, 2003. 8. Marina N, Malogolowkin M, Chang KW, London WB, Frazier AL, Rescorla F, Billmire DF, Davis M, Perlman E, Giller R, Lauer S. “Amifostine does not protect against the ototoxicity associated with high-dose cisplatin, etoposide, and bleomycin (HD-PEB) in pediatric germ cell tumors.” Children’s Oncology Group 2003 Fall Group Meeting, Dallas, Texas, November 4-9, 2003. 9. Choe W, Chinosornvatana N, Chang KW. “Anti-oxidant prevention of cisplatin ototoxicity.” American Otologic Society Spring COSM, Phoenix, Arizona, May 1-2, 2004. 10. Chang KW. “Randomized controlled trial of Coblation versus electrocautery tonsillectomy.” AAO-HNS Annual Meeting, New York City, Sept 20, 2004. 11. Schrijver I, Chang KW. “Two patients with the V37I/235delC genotype: Are radiographic cochlear anomalies part of the phenotype?” 5th Molecular Biology of Hearing and Deafness Conference, Bethesda, Maryland, Sept 30-Oct 3, 2004. Curriculum Vitae Kay W. Chang, MD 9 12. Messner AH, Chang KW, Friedman N. “Obstructive Sleep Apnea – What Do We Look For?” American Academy of Pediatrics 2004 National Conference & Exhibition, Moscone Convention Center, San Francisco, CA, October 9, 2004. 13. Monfared A, Blevins NH, Cheung ELM, Jung J, Popelka G, Chang K, Jackson R, Schnitzer M. “Fluorescence microendoscopy of the mammalian inner ear.” American Neurotology Society Spring COSM, Boca Raton, Florida, May 14-15, 2005. 14. Koltai P, Chang K, Gianonni C, April M. “Controversies in tonsillectomy surgery.” American Society of Pediatric Otolaryngology 2005 Annual Meeting, Las Vegas, Nevada, May 27-30, 2005. 15. Chang KW. “Tonsil surgery in the 21st Century: different opinions.” Moderator. 6th International Symposium on Tonsils and Mucosal Barriers of the Upper Airways (I.S.T.M.B.), Siena, Italy, August 31 – September 3, 2006. 16. Chang KW. “Coblation tonsillectomy.” 6th International Symposium on Tonsils and Mucosal Barriers of the Upper Airways (I.S.T.M.B.), Siena, Italy, September 1, 2006 17. Chang KW. “Expanding indications for BAHA.” SENTAC Pre-conference Symposium, Improving Auditory (re)Habilitation, San Francisco, November 30, 2006 18. Chang KW, Kazahaya K, O’Reilly R, Arjmand E, Papaioannou V, Larky J, Gordon K. “Bilateral Cochlear Implantation” SENTAC Panel, San Francisco, December 1, 2006. 19. Chang KW. “Intracapsular versus subcapsular Coblation tonsillectomy.” SENTAC 34th Annual Meeting, San Francisco, December 2, 2006. 20. Curtin G, Messner A, Chang KW, Silva WJ, Diamond M. “Optimizing care for patients in a pediatric long-term care facility.” SENTAC 34th Annual Meeting, San Francisco, December 3, 2006 21. Chang K. “Coblation tonsillectomy techniques.” Northwest and Oregon Academies of Otolaryngology Mid-Winter Meeting, Whistler BC, January 15, 2007. 22. Papsin B, Sie K, Brenski A, Chang K, Manning S. “Pediatric conductive hearing loss, BAHA, and atresia.” Northwest and Oregon Academies of Otolaryngology Mid-Winter Meeting, Whistler BC, January 15, 2007. 23. Chen J, Chang KW. “Utility of temporal bone CT measurements in the evaluation of inner ear malformations.” American Society of Pediatric Otolaryngology 2007 Annual Meeting, San Diego, California, April 29, 2007. 24. O-Lee TJ, Price M, Chang KW. “Evaluation of unilateral refers on neonatal hearing screening.” American Society of Pediatric Otolaryngology 2007 Annual Meeting, San Diego, California, April 27-29, 2007. 25. Truong MT, Koltai PJ, O-Lee TJ, Messner AH, Chang KW. “Pediatric Sleep Endoscopy.” American Academy of Otolaryngology-Head and Neck Surgery 2007 Annual Meeting, Washington DC, September 17, 2007. 26. Koltai P, Chang K. “Intracapsular tonsillectomy: Microdebrider and Coblation.” American Academy of Otolaryngology-Head and Neck Surgery 2007 Annual Meeting, Course # 3834-1, Washington DC, September 18, 2007. 27. Chang KW. “The latest techniques in tonsillectomy.” UCSF Otolaryngology Update: 2007, San Francisco, CA, November 8, 2007. 28. Swamy R, Chang K, Winzelberg J. “Longitudinal audiologic evaluation of children with Downs syndrome.” American Society of Pediatric Otolaryngology 2008 Annual Meeting, Orlando, Florida, May 2-4, 2008. Curriculum Vitae Kay W. Chang, MD 10 29. Papsin B, Chang K, Mileshina N, Unal O. “Microtia, Aural Atresia Round Table.” 8 th International Conference of the European Society of Pediatric Otolaryngology, Budapest, Hungary, June 10, 2008. 30. Chang KW, Huang E, Carlson GA, Vose JG. “Evaluation of the PEAK PlasmaBlade for ENT surgery.” American Academy of Otolaryngology-Head and Neck Surgery 2008 Annual Meeting, Chicago, IL, September 21, 2008. 31. Koltai P, Chang K. “Intracapsular tonsillectomy: Microdebrider and Coblation.” American Academy of Otolaryngology-Head and Neck Surgery 2008 Annual Meeting, Course # 2729-1, Chicago, IL, September 22, 2008. 32. Chan DK, Schrijver I, Chang KW. “Evidence for progression in Connexin-26-associated hearing loss.” American Society of Pediatric Otolaryngology 2009 Annual Meeting, Seattle, Washington, May 23, 2009. 33. Truong MT, Callahan K, Bruckner A, McKenney A, Chang K. “Oral propranolol; The end to surgical management of subglottic hemangiomas?” American Society of Pediatric Otolaryngology 2009 Annual Meeting, Seattle, Washington, May 24, 2009. 34. Mori M, Chang K. “CT analysis shows cochlear height does not change with age.” American Academy of Otolaryngology-Head and Neck Surgery 2009 Annual Meeting, San Diego, CA, October 4-7, 2009. 35. Koltai P, Chang K. “Intracapsular tonsillectomy: Microdebrider and Coblation.” American Academy of Otolaryngology-Head and Neck Surgery 2009 Annual Meeting, Course # 3832-1, San Diego, CA, October 6, 2009. 36. Truong MT, Chang K, Messner A. “Propranolol for the treatment of airway hemangiomas.” American Academy of Otolaryngology-Head and Neck Surgery 2009 Annual Meeting, San Diego, CA, October 7, 2009. 37. Kohlberg GD, Truong MT, Chang KW. “Wegener’s granulomatosis in an adolescent presenting with pachymeningitis, mastoid effusion and Horner’s syndrome.” SENTAC 37 th Annual Meeting, Salt Lake City, UT, December 3-6, 2009. 38. Chan DK, Schrijver I, Chang KW. “Connexin 26-associated deafness: Association of a single common allele with progressive hearing loss.” American Otologic Society Spring COSM, Las Vegas, NV, May 1, 2010. 39. Chang KW, Knight K. “Clinical study of ototoxicity in children.” 42 nd Congress of the International Society of Pediatric Oncology (SIOP), Ototoxicity Consensus Conference, Boston, MA, October 23-24, 2010. 40. Chisholm KM, Chang KW, Truong MT, Kwok S, West RB, Heerema-McKenney A. “Beta adrenergic receptor expression in pediatric vascular lesions.” Society for Pediatric Pathology 2011 Annual Meeting, San Antonio, TX, February 27, 2011. 41. Brewer C, Knight K, Fligor B, Grimes A, Brooks B, Chang K. “Guidelines for monitoring and grading pediatric ototoxicity.” American Academy of Audiology AudiologyNOW! 2011 Annual Meeting, Chicago, IL, April 8, 2011. 42. Gurgel RK, Popelka G, Oghalai JS, Blevins NH, Chang KW, Jackler R. “Correlation of measured versus averaged 3 kHz pure tone averages.” American Academy of Otolaryngology-Head and Neck Surgery 2011 Annual Meeting, San Francisco, CA, September 14, 2011. 43. Colevas AD, Lira RR, Colevas EA, Lavori PW, Chang KW. “Hearing evaluation of head and neck cancer patients (HNCP): Comparison of adverse event (AE) criteria.” American Society of Curriculum Vitae Kay W. Chang, MD 11 Clinical Oncology (ASCO) 2012 Annual Meeting, Chicago, IL, June 1-5, 2012. citation: J Clin Oncol 30, 2012 (suppl; abstr 5525) 44. Hoff SR, Chang KW. “Stuck: Proximal balloon dilation technique for removal of embedded distal airway foreign bodies.” American Academy of Otolaryngology-Head and Neck Surgery 2012 Annual Meeting, Washington, DC, September 10, 2012. 45. Chan DK, Chang KW. “GJB2 associated hearing loss: Systematic review of worldwide prevalence, genotype, and auditory phenotype.” Triological Society 116 th Annual Meeting Spring COSM, Orlando, FL, April 12, 2013. 46. Nadaraja GS, Gurgel RK, Chang KW. “Hearing outcomes of atresia surgery versus boneanchored hearing aid in patients with congenital aural atresia: A systematic review.” American Otological Society 146th Annual Meeting Spring COSM, Orlando, FL, April 13, 2013. 47. Lee DH, Knight KR, Chang KW. “Validity of audiogram threshold interpolation in pediatric oncology patients.” American Society of Pediatric Otolaryngology 28th Annual Meeting, Arlington, VA, April 25-28, 2013. 48. Czechowicz JA, Chang KW. “Longitudinal analysis of growth curves in children following adenotonsillectomy.” American Society of Pediatric Otolaryngology 28th Annual Meeting, Arlington, VA, April 26, 2013. 49. Sefi E, Brock P, Chang K, Neuwelt E, Knight K, Rajput K. “Validation of the SIOP Boston ototoxicity scale: An international scale for the evaluation of platinum-induced ototoxicity in cihldren.” 45th Congress of the International Society of Paediatric Oncology, Hong Kong, China, September 27, 2013. 50. Chang KW. “Coblation techniques: Total, Intracapsular, and Lingual Tonsillectomy.” SENTAC Pre-Conference Symposium (Tonsillectomy & Adenoidectomy: Care & Controversies), December 5, 2013. 51. Czechowicz JA, Chang KW. “Impact of supraglottoplasty on growth and development of infants with laryngomalacia.” American Society of Pediatric Otolaryngology 29th Annual Meeting, Las Vegas, NV, May 16, 2014. 52. Bass JK, Hua C, Huang J, Onar-Thomas A, Ness KK, Jones S, White S, Bhagat SP, Chang KW, Merchant TE. “Incidence, onset, severity, and long-term progression of hearing loss in patients treated with cranial radiation therapy for childhood cancer.” European Symposium on Late Complications After Childhood Cancer, Edinburgh, Scotland, September 15-16, 2014. 53. Chang KW. “Hearing outcomes of atresia surgery and auditory implants in patients with congenital aural atresia.” 1st Congress of the International Society of Auricular Reconstruction, Paris, France, September 27, 2014. 54. Chang KW. “Comparison of thinning vs non-thinning techniques for placement of Ponto osseointegrated auditory implants in children.” 14th Symposium on Cochlear Implants in Children, Nashville, TN, December 11, 2014. 55. Chang KW. “Comparison of thinning vs non-thinning techniques for placement of Ponto osseointegrated auditory implants in children.” 10th Asia Pacific Symposium on Cochlear Implants and Related Sciences, China National Convention Center, Beijing, China, May 1, 2015. 56. Chang KW. “Hearing outcomes of atresia surgery versus bone anchored implants in patients with congenital aural atresia: A systematic review.” 10th Asia Pacific Symposium on Cochlear Implants and Related Sciences, China National Convention Center, Beijing, China, May 1, 2015. 57. Chang KW, Oghalai JS. “Cognitive outcomes and familial stress after cochlear implantation in deaf children with and without developmental delays.” 10 th Asia Pacific Symposium on Curriculum Vitae Kay W. Chang, MD 12 Cochlear Implants and Related Sciences, China National Convention Center, Beijing, China, May 2, 2015. 58. Chang KW. “Comparison of thinning vs non-thinning techniques for bone anchored implants.” 5th International Congress on Bone Conduction Hearing and Related Technologies, Lake Louise, Canada, May 21, 2015. 59. Chang KW. “Assessment and prevention of ototoxicity in children receiving chemotherapy.” AAO-HNSF 2015 Annual Meeting Miniseminar: “Ototoxic or not: Innovations in the management of ototoxicity”, Dallas, Texas, September 28, 2015. 60. Chang KW. “Update on radiological and genetic evaluation of congenital SNHL.” 1st Cairo Cochlear Implant Congress, Intercontinental Cairo Semiramis Hotel, Cairo, Egypt, February 6, 2016. 61. Chang KW. “Pediatric cochlear implantation: Indications, techniques, and future directions.” 1st Cairo Cochlear Implant Congress, Intercontinental Cairo Semiramis Hotel, Cairo, Egypt, February 7, 2016. 62. Chang KW, Amoils M, Popelka GR, Kearns J, Larky J, Farquhar M, Sussman K, Blevins NH, Fitzgerald MB. “The BabyTalk Program: Factors influencing auditory development after teletherapy in children with hearing loss ages 0-3 years.” 1st Cairo Cochlear Implant Congress, Intercontinental Cairo Semiramis Hotel, Cairo, Egypt, February 7, 2016. 63. Bliss MR, Truong MT, Chang KW. “Three dimensional printing in microtia repair: Facilitating teaching and achieving symmetry.” Triological Society Spring COSM, Chicago, IL, May 20, 2016. 64. Baird BJ, Chang KW. “Oral mucocutaneous manifestation of EBV-associated lymphoproliferative disorder in a healthy pediatric patient.” American Society of Pediatric Otolaryngology Spring COSM, Chicago, IL, May 20, 2016. INVITED PRESENTATIONS 1. Chang KW. “Failed newborn hearing screening – what to do next?” 76th Annual Postgraduate Convention, Loma Linda, March 2, 2008. 2. Chang KW. “Advances in tonsillectomy: Technology vs. technique.” 76 th Annual Postgraduate Convention, Loma Linda, March 2, 2008. 3. Chang KW. “Advances in tonsillectomy: technology vs. technique.” Symposium on Coblation Innovation. COSM 2008, Orlando, May 2, 2008. 4. Chang KW. “What’s new in tonsillectomy technology.” 2010 Ultimate Colorado Mid-Winter Meeting, Vail, Colorado, January 26, 2010. 5. Chang KW. “Assessment of ototoxicity in chemotherapy patients.” Oregon Health Sciences University, Multnomah Athletic Club, Portland, OR, October 11, 2010. 6. Chang KW. “Current concepts in the evaluation of pediatric SNHL.” Oregon Health Sciences University, Department of Otolaryngology SJH 5314, Portland, OR, October 12, 2010. 7. Chang KW. “Current concepts in the evaluation of congenital sensorineural hearing loss.” Tongren Hospital, Beijing, China, January 4, 2012. 8. Chang KW. “Beyond T&A: Options for persisting pediatric OSA after adenotonsillectomy.” Beijing Children’s Hospital, Beijing, China, January 5, 2012. 9. Chang KW. “Current concepts in the evaluation of congenital sensorineural hearing loss.” Eye & ENT Hospital of Fudan University, Shanghai, China, January 11, 2012. Curriculum Vitae Kay W. Chang, MD 13 10. Chang KW. “Current concepts in the practical evaluation of congenital SNHL with radiology and genetics.” 2012 Ultimate Colorado Mid-Winter Meeting, Vail, Colorado, February 5, 2012. 11. Grundfast K, Casselbrant M, Carvalho D, Chang K, Lusk R. “Common pediatric otologic dilemmas.” 2012 Ultimate Colorado Mid-Winter Meeting, Vail, Colorado, February 5, 2012. 12. Chang KW, Messner AH. “Optimizing postoperative recovery of the tonsillectomy patient.” 2012 Ultimate Colorado Mid-Winter Meeting, Vail, Colorado, February 5, 2012. 13. Pransky S, Prager J, Manning S, Chang K. “Pediatric airway round table.” 2012 Ultimate Colorado Mid-Winter Meeting, Vail, Colorado, February 5, 2012. 14. Chang KW. “Clinically accurate assessment and grading of ototoxicity in pediatric oncology patients.” CPC Seminar, St. Jude Children’s Research Hospital, Memphis, Tennessee, October 1, 2012. 15. Chang KW. “Evaluation of cisplatin ototoxicity.” Memphis Speech & Hearing Center (MSHC), University of Memphis, Memphis, Tennessee, October 2, 2012. 16. Chang KW. “Emerging trends in the diagnosis of congenital SNHL.” 2013 Ultimate Colorado Mid-Winter Meeting, Vail, Colorado, February 6, 2013. 17. Chang KW. “Guest professorship: Microtia and canal atresia reconstruction.” Eye & ENT Hospital of Fudan University, Shanghai, China, January 8-10, 2014. 18. Chang KW. “Issues in pediatric bone anchored implant surgery.” Oticon Medical Scientific Meeting, Copenhagen, Denmark, January 27, 2014. 19. Chang KW. “Coblation techniques for treatment of sleep disturbed breathing.” 2014 Ultimate Colorado Mid-Winter Meeting, Vail, Colorado, February 5, 2014. 20. Chang KW. “Workup of child with congenital sensorineural hearing loss.” 2014 Ultimate Colorado Mid-Winter Meeting, Vail, Colorado, February 6, 2014. 21. Chang KW. Keynote: “Hearing outcomes of atresia surgery in patients with congenital aural atresia.” 2014 Shanghai International Symposium on Microtia-Atresia and Hearing Reconstruction, Shanghai, China, March 16, 2014. 22. Chang KW. Keynote: “Emerging trends in the diagnosis of congenital SNHL.” 96 th Annual Taiwan Otolaryngology Society Meeting, Hsinchu, Taiwan, May 3, 2014. 23. Chang KW. Keynote: “Options for audiological rehabilitation in patients undergoing ear reconstruction.” 1st Congress of the International Society of Auricular Reconstruction, Paris, France, September 27, 2014. 24. Backous D, Chang KW. (moderators) “Advancements in implant surgery.” 14th Symposium on Cochlear Implants in Children, Nashville, TN, December 11, 2014. 25. Chang KW. “Hearing outcomes of atresia surgery versus bone-anchored hearing aid in patients with congenital aural atresia.” 2015 Ultimate Colorado Mid-Winter Meeting, Vail, Colorado, February 3, 2015. 26. Chang KW, Knight K (co-chairs). “Assessment of Ototoxicity.” 21st Annual Blood-Brain Barrier Consortium Meeting, Stevenson, WA, March 19-21, 2015. 27. Chang KW. “Panelist of Roundtable Discussion on Bone-Anchored Hearing Aids & Bonebridge.” 10th Asia Pacific Symposium on Cochlear Implants and Related Sciences, China National Convention Center, Beijing, China, May 1, 2015. 28. Chang KW (moderator). AAO-HNSF 2015 Annual Meeting Miniseminar: “Ototoxic or not: Innovations in the management of ototoxicity”, Dallas, Texas, September 28, 2015. Curriculum Vitae Kay W. Chang, MD 14 29. Chang KW. “Options for audiological management of congenital aural atresia.” The 2 nd China International Forum of Pediatric Development, Pediatric Otolaryngology Session, Beijing, China, October 10, 2015. 30. Naseer UA, Chang KW, Sheikh AE, Ruiz MA, Olgun L, Chiossone JA, Lavy J, El khaboury M, George M, Chaudry I, De Raeve L. “Global cochlear implantation economics: Current status and future prospects.” (round-table discussion) 1st Cairo Cochlear Implant Congress, Intercontinental Cairo Semiramis Hotel, Cairo, Egypt, February 5, 2016. 31. Müller J, Chang KW, Handousa A, Khater A, Wahba H, Taibah K, De Raeve L, Ruiz MA, Donnelly N. “Binaural hearing in CI.” (panel) 1st Cairo Cochlear Implant Congress, Intercontinental Cairo Semiramis Hotel, Cairo, Egypt, February 6, 2016. 32. Naseer UA, Chang KW, Baki FA, Kassouma J, Müller J, Chiossone JA, Kandari M, Khalil S, El Dessouky T. “CI device selection.” (panel) 1st Cairo Cochlear Implant Congress, Intercontinental Cairo Semiramis Hotel, Cairo, Egypt, February 7, 2016. 33. Chang K, Choo, D, Don D, Freyer D, Geller J, Hayashi R, Lee A, Lieu J, Rangaswami A, Waldman E. “OTO-104 Otoprotection Expert Panel.” St. Louis, MO, March 11, 2016. CME COURSES AND OTHER PRESENTATIONS 1. Chang KW. “Pediatric obstructive sleep apnea.” Presented at Grand Rounds, Pittsburgh, PA, January 13, 1999. 2. Chang KW. “The Cochlear Amplifier: Concepts and experiments in auditory physiology.” Presented at Grand Rounds, Pittsburgh, PA, January 12, 2000. 3. Chang KW. “Update in Pediatric Otolaryngology.” Presented at ENT Grand Rounds, Stanford University, CA, September 7, 2000. 4. Chang KW. “Pediatric obstructive sleep apnea.” Resident Education Conference, Stanford University, CA, September 21, 2000. 5. Chang KW. “Pediatric hearing loss.” Resident Education Conference, Stanford University, CA, January 18, 2001. 6. Chang KW. “Evaluation and management of ear problems in children.” Pediatric Grand Rounds, Stanford University, CA, April 27, 2001. 7. Chang KW. “External and middle ear effects on otoacoustic emissions.” Seminar: Clinical Applications of Otoacoustic Emissions, Lucile Packard Children’s Hospital, Department of Pediatric Audiology, June 16, 2001. 8. Chang KW. “Ear problems in the pediatric population.” Ninth Annual Pediatric Update (CME meeting), July 20-21, 2001. 9. Chang KW. “Monitoring and management of ototoxic therapies.” Presented at ENT Grand Rounds, Stanford University, CA, December 6, 2001. 10. Chang KW. “Panel Discussion: Atelectasis.” Western Section of the American Society of Pediatric Otolaryngology (WESPO) Annual Meeting, Lucile Packard Children’s Hospital, March 16, 2002. 11. Chang KW. “Monitoring and management of ototoxic therapies.” Annual Symposium, Stanford University, June 21, 2002. 12. Chang KW, Tran L. “Cochlear embryology and physiology.” Resident Education Conference, Stanford University, November 7, 2002. Curriculum Vitae Kay W. Chang, MD 15 13. Chang KW, Pollard J. “Pediatric obstructive sleep apnea.” Resident Education Conference, Stanford University, March 6, 2003. 14. Chang KW. “Pediatric Airway Update 2003.” Annual Symposium, Stanford University, June 21, 2003. 15. Chang KW. “An in vivo model for the prevention of cisplatin-induced ototoxicity using lactate and N-acetylcysteine.” Pediatric Oncology Conference, LPCH Board Room, March 11, 2004. 16. Chang KW. “Congenital Problems.” Temporal Bone Microdissection Lab – Pediatric Otology, Stanford University, February 28, 2004. 17. Chang KW, Ruffy M. “Embryology of the Head & Neck.” Resident Education Conference, Stanford University, April 29, 2004. 18. Chang KW. “Congenital Malformations of the Ear.” Resident Education Conference, Stanford University, April 29, 2004. 19. Chang KW. “Evaluation and management of congenital ear problems.” LPCH CME Course, Pismo Beach Pediatric Clinical Update, San Luis Obispo, CA, May 22, 2004. 20. Chang KW, Chen J. “Evaluation of the child with sensory hearing loss.” Resident Education Conference, Stanford University, May 27, 2004. 21. Chang KW. “Is CO2 laser still standard therapy for RRP?” Annual Symposium, Stanford University, June 19, 2004. 22. Chang KW. “What a pediatrician needs to know about cochlear implants.” 12 th Annual Pediatric Update, Frances C. Arrillaga Alumni Center, Stanford University, July 17, 2004. 23. Chang KW. “Microtia and ear canal atresia.” Pediatric Otolaryngology Update 2004, LPCH CME Course, The Ritz-Carlton, San Francisco, November 6, 2004. 24. Chang KW. “What to expect from pediatric cochlear implants.” Pediatric Otolaryngology Update 2004, LPCH CME Course, The Ritz-Carlton, San Francisco, November 7, 2004. 25. Nguyen B, Barnes P, Chang KW. “Utility of temporal bone CT measurements in the evaluation of inner ear malformations resulting in sensorineural hearing loss.” Medical Student Research Symposium, Stanford University, May 11, 2005. 26. Chang KW. “Microtia and ear canal atresia.” Temporal Bone Microdissection Lab – Pediatric Otology, Stanford University, May 21, 2005. 27. Blevins N, Chang KW, Larky J. “Cochlear implants: Better hearing through advanced technology: What, when, and for whom?” Fairchild Auditorium, Stanford University, June 16, 2005. 28. Chang KW. “Treatment of vocal cord paralysis in children.” Annual Symposium, Stanford University, June 18, 2005. 29. Chang KW, Swamy R. “Evaluation of the child with sensorineural hearing loss.” Resident Education Conference, Stanford University, March 30, 2006. 30. Chang KW, Sunder S. “Congenital malformations of the ear.” Resident Education Conference, Stanford University, March 30, 2006. 31. Chinosornvatana N, Chang KW. “Grading of ototoxicity.” Medical Student Research Symposium, Stanford University, May 17, 2006. 32. Chang KW. “Innovations in pediatric tonsillectomy.” Invited speaker. Palo Alto Medical Foundation, July 18, 2006. Curriculum Vitae Kay W. Chang, MD 16 33. Chang KW. “Complications of otitis media.” Pediatric Otolaryngology Update 2006, LPCH CME Course, Crowne Plaza Cabana, Palo Alto, October 27, 2006. 34. Chang KW. “Atypical mycobacterial infections.” Pediatric Otolaryngology Update 2006, LPCH CME Course, Crowne Plaza Cabana, Palo Alto, October 27, 2006. 35. Chang KW. “Managing tympanic membrane perforations.” Pediatric Otolaryngology Update 2006, LPCH CME Course, Crowne Plaza Cabana, Palo Alto, October 27, 2006. 36. Chang KW. “Panel: Otitis Media.” Pediatric Otolaryngology Update 2006, LPCH CME Course, Crowne Plaza Cabana, Palo Alto, October 27, 2006. 37. Chang KW. “Management of Microtia and Atresia.” Stanford Otology & Neurotology Update 2006, Stanford CME Course, Stanford Court Hotel, San Francisco, November 3, 2006. 38. Chang KW. “Ototoxicity and Chemoprotection.” Stanford Otology & Neurotology Update 2006, Stanford CME Course, Stanford Court Hotel, San Francisco, November 3, 2006. 39. Chang KW. “Congenital atresia.” Temporal Bone Microdissection Lab – Pediatric Otology, Stanford University, March 26, 2007. 40. Chang KW, Sunder S. “Evaluation of ototoxicity and chemoprotective strategies.” Resident Education Conference, Stanford University, May 24, 2007. 41. Chang KW. “Congenital laryngeal stenosis.” Annual Symposium, Stanford University, June 23, 2007. 42. Chang KW. “Clinically relevant assessment and classification of drug-induced ototoxicity in pediatric patients.” Pediatric Pulmonary Conference, LPCH, September 27, 2007. 43. Chang KW. “Debate: Is surgery for chronic sinusitis in children indicated?” Pediatric Otolaryngology Update 2008, LPCH CME Course, Crowne Plaza Cabana, Palo Alto, March 28, 2008. 44. Chang KW. “Update on laryngeal stenosis.” Pediatric Otolaryngology Update 2008, LPCH CME Course, Crowne Plaza Cabana, Palo Alto, March 29, 2008. 45. Chang KW. “Pediatric Otology: Congenital Ear Anomalies.” Temporal Bone Microdissection Lab – Pediatric Otology, Stanford University, April 28, 2008. 46. Chang KW. “Management of Microtia and Atresia.” Stanford Otology & Neurotology Update 2008, Stanford CME Course, Stanford Court Hotel, San Francisco, November 6, 2008. 47. Chang KW. “Pearls and pitfalls in interpreting auditory physiologic studies in pediatric patients.” Resident Education Conference, Stanford University, January 29, 2009. 48. Chang KW. “Pediatric Otology: Congenital Ear Anomalies.” Temporal Bone Microdissection Lab – Pediatric Otology, Stanford University, May 18, 2009. 49. Chang KW. “A practical grading system for evaluating cisplatin ototoxicity in children.” LPCH Pediatric Oncology Protocol Meeting, Stanford University, September 23, 2009. 50. Chang KW. “Atresia and congenital conductive hearing loss.” Chandler Tripp School, San Jose, October 27, 2009. 51. Popelka GR, Chang KW. “Practical methods for monitoring ototoxicity in chemotherapy patients.” Cancer Education Seminar Series, Stanford University School of Medicine Division of Oncology, December 1, 2009. 52. Chang KW. “Work-up of pediatric SNHL.” Resident Education Conference, Stanford University, April 8, 2010. Curriculum Vitae Kay W. Chang, MD 17 53. Chang KW. “Assessment of Ototoxicity in Chemotherapy Patients.” Pediatric Research Study Group, Alway Medical Center Building M212, Stanford University School of Medicine, April 26, 2010. 54. Chang KW. “Neonatal unilateral hearing screen referrals, canal atresia, and microtia,” NICU Clinical Consensus Conference, Lucile Packard Children’s Hospital at Stanford, May 24, 2010. 55. Oghalai J, Blevins N, Chang KW, Cheng A, Lalwani A, Lustig L, Telian S. “Hearing Loss in Children.” Stanford Otology Course 2010, Stanford CME Course, Li Ka Shing Center for Learning & Knowledge, Stanford University, November 5, 2010. 56. Chang KW. “How to not miss a cholesteatoma.” Pediatric Otolaryngology Update 2011, LPCH CME Course, Li Ka Shing Center for Learning and Knowledge, Stanford, CA, February 11, 2011. 57. Chang KW, Cheng A, Oghalai J, Rosbe K, Rosen F, Winzelberg J. “How best to care for the child with a unilateral hearing loss.” Pediatric Otolaryngology Update 2011, LPCH CME Course, Li Ka Shing Center for Learning and Knowledge, Stanford, CA, February 11, 2011. 58. Chang KW, Winzelberg J. “Audiometric interpretation.” Pediatric Otolaryngology Update 2011, LPCH CME Course, Li Ka Shing Center for Learning and Knowledge, Stanford, CA, February 12, 2011. 59. Chang KW. “Pediatric Audiology.” Resident Education Conference, Stanford University, February 2, 2012. 60. Chang KW. “Genetic hearing loss.” Resident Education Conference, Stanford University, February 9, 2012. 61. Chang KW. “Does treating gastroesophageal reflux help babies with laryngomalacia?” Intensive Course in Clinical Research (ICCR), Stanford Center for Clinical and Translational Education and Research, March 30, 2012. 62. Anavitarte A, Winzelberg J, Chang K, Cheng A. “The effect of unilateral hearing loss on speech and language development.” 29th Annual Medical Student Research Symposium, Stanford University School of Medicine, May 3, 2012. 63. Chang KW. “The medical work-up of pediatric SNHL.” Haman Elementary School, Santa Clara, California, May 15, 2012. 64. Lee J, Chang KW. “Grading of ototoxicity in children.” 2012 Residency Research Symposium, Stanford, California, June 15, 2012. 65. Chan DK, Chang KW. “GJB2-associated hearing loss: genotypic and phenotypic variability.” 2012 Residency Research Symposium, Stanford, California, June 15, 2012. (won 1st prize) 66. Nadaraja G, Chang KW. “Hearing outcomes of surgery versus BAHA in patients with congenital aural atresia: A systematic review.” 2012 Residency Research Symposium, Stanford, California, June 15, 2012. (won runner-up prize) 67. Oghalai J, Chang KW, Cheng A, Welling DB. “Pediatric Otology.” Stanford Otology Course 2012, Stanford CME Course, Li Ka Shing Center for Learning & Knowledge, Stanford University, November 1-3, 2012. 68. Chang KW. “Minimizing the effects of ototoxicity-induced hearing loss in children receiving chemotherapy.” OHNS Research Day, Clark Auditorium, Stanford University, November 16, 2012. 69. Chang KW. “Congenital anomalies of the external and middle ears.” Resident Education Conference, Stanford University, March 21, 2013. Curriculum Vitae Kay W. Chang, MD 18 70. Chang KW. “Can standardization of ototoxicity reporting using the SIOP Ototoxicity Scale help improve clinical trials to reduce ototoxicity in pediatric oncology patients?” Peds Hem/Onc Faculty Research Conference, Lokey Stem Cell G1161 Large Conference Room, Stanford University, June 14, 2013. 71. Czechowizc J, Chang KW. “Analysis of growth curves in children following adenotonsillectomy.” 2013 Residency Research Symposium, Stanford, California, June 14, 2013. (won runner-up prize) 72. Lee J, Chang KW. “Validity of audiogram threshold interpolation in pediatric oncology patients.” 2013 Residency Research Symposium, Stanford, California, June 14, 2013. 73. Chang KW. “Evolution of treatments for permanent pediatric CHL.” Resident Education Conference, Stanford University, March 27, 2014. 74. Czechowizc J, Chang KW. “Impact of supraglottoplasty on growth and development of infants with laryngomalacia.” 2014 Residency Research Symposium, Stanford, California, June 13, 2014. 75. Chang KW. “Managing Atresia/Microtia.” Stanford Otology Course 2014, Stanford CME Course, Li Ka Shing Center for Learning & Knowledge, Stanford University, November 8, 2014. 76. Chang KW. “Issues in pediatric bone-anchored implant surgery: Challenges met by modern tissue preservation surgical technique.” 1st Oticon Medical China Scientific Seminar on Middle Ear Implants, Hong Kong, November 12, 2014. 77. Chang KW. “Issues in pediatric bone-anchored implant surgery: Challenges met by modern tissue preservation surgical technique.” 1st Oticon Medical China Scientific Seminar on Middle Ear Implants, Beijing, November 14, 2014. 78. Chang KW. “Monitoring the effects of ototoxicity-induced hearing loss in children receiving chemotherapy.” Pediatric Audiology Conference, Stanford Ear Institute, February 17, 2015. 79. Chang KW. “Management of pediatric atresia and microtia patients.” Resident Education Conference, Stanford University, March 26, 2015. 80. Chang KW. “Tissue preservation technique for bone anchored implants in children.” Oticon Medical Scientific Symposium, China National Convention Center, Beijing, China, May 1, 2015. 81. Chang KW. “T&A Today: New Techniques and Tools.” Primary Care Challenges in Pediatric Otolaryngology: A Case-Based Approach, Stanford CME Course, Monterey, CA, May 8, 2015. 82. Chang KW. “Clinical Practice Guidelines for Otitis Media.” Primary Care Challenges in Pediatric Otolaryngology: A Case-Based Approach, Stanford CME Course, Monterey, CA, May 9, 2015. 83. Chang KW. “Microtia: Latest Ideas for World Class Results.” Primary Care Challenges in Pediatric Otolaryngology: A Case-Based Approach, Stanford CME Course, Monterey, CA, May 9, 2015. 84. Chang KW. “Ear Cases and Q&A.” Primary Care Challenges in Pediatric Otolaryngology: A Case-Based Approach, Stanford CME Course, Monterey, CA, May 9, 2015. 85. Chang KW. “Microtia and canal atresia reconstruction.” Chandler Tripp School, San Jose, May 18, 2015. 86. Chang KW. “Coblation techniques for treatment of tonsillar hypertrophy.” AAO-HNSF 2015 Annual Meeting, Exhibit Hall Product Theater, Dallas, Texas, September 28, 2015. 87. Chang KW. “Assessment and prevention of ototoxicity in children receiving chemotherapy.” OHNS Research Day, Li Ka Shing Center Berg Hall, Stanford University, October 30, 2015. Curriculum Vitae Kay W. Chang, MD 88. Chang KW. “Microtia and Atresia: Latest Ideas for World Class Results.” Chandler Tripp School, San Jose, May 16, 2016. 19